Serum neopterin levels in relation to mild and severe COVID-19.

Josefina RobertsonJohanna M GostnerStaffan NilssonLars-Magnus AnderssonDietmar FuchsMagnus Gisslen

Published in: BMC infectious diseases (2020)

In conclusion, we found that serum neopterin levels are associated with the severity of COVID-19. Our findings suggest that neopterin could be used as a prognostic marker, but further studies are needed to elucidate how it can be used in the clinic.

Keyphrases

coronavirus disease
sars cov
primary care
respiratory syndrome coronavirus
early onset
drug induced